NEWS AND EVENTS

27
Oct
Velicept Therapeutics, Inc. Names Clarence Young, M.D., Chief Medical Officer

Velicept Therapeutics, Inc. announced today Clarence Young, M.D. has joined its leadership team as the company’s Chief Medical Officer.

Posted in: Uncategorized,
05
Oct
VELICEPT THERAPEUTICS ANNOUNCES FDA ACCEPTANCE OF IND APPLICATION OF NOVEL, ONCE-DAILY FORMULATION OF SOLABEGRON FOR THE TREATMENT OF OVERACTIVE BLADDER

Malvern, PA, October 5, 2016 (BUSINESS WIRE) – Velicept Therapeutics, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application to initiate a Phase I pharmacokinetic study for a once-daily formulation for solabegron.

Posted in: Uncategorized,
01
Dec
Velicept Therapeutics, Inc. Raises $21 Million in Series B Financing

Malvern, PA, December 1, 2015 (BUSINESS WIRE) – Velicept Therapeutics, Inc. announced today it has closed on the first tranche of a $21 million Series B financing…

Posted in: Press Release,